Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087122386> ?p ?o ?g. }
- W3087122386 endingPage "48" @default.
- W3087122386 startingPage "48" @default.
- W3087122386 abstract "Population-based seroepidemiological studies measure the extent of SARS-CoV-2 infection in a country. We report the findings of the first round of a national serosurvey, conducted to estimate the seroprevalence of SARS-CoV-2 infection among adult population of India.From May 11 to June 4, 2020, a randomly sampled, community-based survey was conducted in 700 villages/wards, selected from the 70 districts of the 21 States of India, categorized into four strata based on the incidence of reported COVID-19 cases. Four hundred adults per district were enrolled from 10 clusters with one adult per household. Serum samples were tested for IgG antibodies using COVID Kavach ELISA kit. All positive serum samples were re-tested using Euroimmun SARS-CoV-2 ELISA. Adjusting for survey design and serial test performance, weighted seroprevalence, number of infections, infection to case ratio (ICR) and infection fatality ratio (IFR) were calculated. Logistic regression was used to determine the factors associated with IgG positivity.Total of 30,283 households were visited and 28,000 individuals were enrolled. Population-weighted seroprevalence after adjusting for test performance was 0.73 per cent [95% confidence interval (CI): 0.34-1.13]. Males, living in urban slums and occupation with high risk of exposure to potentially infected persons were associated with seropositivity. A cumulative 6,468,388 adult infections (95% CI: 3,829,029-11,199,423) were estimated in India by the early May. The overall ICR was between 81.6 (95% CI: 48.3-141.4) and 130.1 (95% CI: 77.0-225.2) with May 11 and May 3, 2020 as plausible reference points for reported cases. The IFR in the surveyed districts from high stratum, where death reporting was more robust, was 11.72 (95% CI: 7.21-19.19) to 15.04 (9.26-24.62) per 10,000 adults, using May 24 and June 1, 2020 as plausible reference points for reported deaths.Seroprevalence of SARS-CoV-2 was low among the adult population in India around the beginning of May 2020. Further national and local serosurveys are recommended to better inform the public health strategy for containment and mitigation of the epidemic in various parts of the country." @default.
- W3087122386 created "2020-09-25" @default.
- W3087122386 creator A5000393786 @default.
- W3087122386 creator A5000927054 @default.
- W3087122386 creator A5001368273 @default.
- W3087122386 creator A5005425852 @default.
- W3087122386 creator A5006331157 @default.
- W3087122386 creator A5006505938 @default.
- W3087122386 creator A5009439501 @default.
- W3087122386 creator A5009644751 @default.
- W3087122386 creator A5010095366 @default.
- W3087122386 creator A5010302103 @default.
- W3087122386 creator A5010334735 @default.
- W3087122386 creator A5010844990 @default.
- W3087122386 creator A5012150863 @default.
- W3087122386 creator A5012789678 @default.
- W3087122386 creator A5014730454 @default.
- W3087122386 creator A5015858694 @default.
- W3087122386 creator A5017648553 @default.
- W3087122386 creator A5018416661 @default.
- W3087122386 creator A5021548349 @default.
- W3087122386 creator A5024208224 @default.
- W3087122386 creator A5026153129 @default.
- W3087122386 creator A5028133542 @default.
- W3087122386 creator A5028550122 @default.
- W3087122386 creator A5029864146 @default.
- W3087122386 creator A5032191543 @default.
- W3087122386 creator A5033950351 @default.
- W3087122386 creator A5034398825 @default.
- W3087122386 creator A5038826897 @default.
- W3087122386 creator A5043581632 @default.
- W3087122386 creator A5044484895 @default.
- W3087122386 creator A5045189861 @default.
- W3087122386 creator A5045796944 @default.
- W3087122386 creator A5046296775 @default.
- W3087122386 creator A5047541472 @default.
- W3087122386 creator A5048572804 @default.
- W3087122386 creator A5049477804 @default.
- W3087122386 creator A5049935253 @default.
- W3087122386 creator A5052744102 @default.
- W3087122386 creator A5055213338 @default.
- W3087122386 creator A5055833524 @default.
- W3087122386 creator A5057601351 @default.
- W3087122386 creator A5060163310 @default.
- W3087122386 creator A5060371530 @default.
- W3087122386 creator A5061273876 @default.
- W3087122386 creator A5061419606 @default.
- W3087122386 creator A5061858117 @default.
- W3087122386 creator A5062885785 @default.
- W3087122386 creator A5064424549 @default.
- W3087122386 creator A5064916269 @default.
- W3087122386 creator A5065323023 @default.
- W3087122386 creator A5065940142 @default.
- W3087122386 creator A5065980378 @default.
- W3087122386 creator A5066699162 @default.
- W3087122386 creator A5067857554 @default.
- W3087122386 creator A5068927114 @default.
- W3087122386 creator A5069034739 @default.
- W3087122386 creator A5070690525 @default.
- W3087122386 creator A5073288112 @default.
- W3087122386 creator A5073417167 @default.
- W3087122386 creator A5074449816 @default.
- W3087122386 creator A5074623171 @default.
- W3087122386 creator A5074842409 @default.
- W3087122386 creator A5075987933 @default.
- W3087122386 creator A5076582132 @default.
- W3087122386 creator A5077213465 @default.
- W3087122386 creator A5079307428 @default.
- W3087122386 creator A5079533457 @default.
- W3087122386 creator A5083176889 @default.
- W3087122386 creator A5084388631 @default.
- W3087122386 creator A5084961890 @default.
- W3087122386 creator A5087487607 @default.
- W3087122386 creator A5088108498 @default.
- W3087122386 creator A5020427494 @default.
- W3087122386 creator A5025004995 @default.
- W3087122386 date "2020-01-01" @default.
- W3087122386 modified "2023-10-13" @default.
- W3087122386 title "Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020" @default.
- W3087122386 cites W1987295152 @default.
- W3087122386 cites W2112746019 @default.
- W3087122386 cites W3017101752 @default.
- W3087122386 cites W3020041202 @default.
- W3087122386 cites W3021590963 @default.
- W3087122386 cites W3023921501 @default.
- W3087122386 cites W3024067230 @default.
- W3087122386 cites W3024178701 @default.
- W3087122386 cites W3025684696 @default.
- W3087122386 cites W3026634552 @default.
- W3087122386 cites W3033139595 @default.
- W3087122386 cites W3034180785 @default.
- W3087122386 cites W3035238050 @default.
- W3087122386 cites W3038553353 @default.
- W3087122386 cites W3040552450 @default.
- W3087122386 cites W3041891181 @default.
- W3087122386 cites W3043342124 @default.
- W3087122386 cites W3049246521 @default.
- W3087122386 cites W4238683035 @default.